Research analysts at StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
TRACON Pharmaceuticals Stock Performance
Shares of TCON opened at $0.03 on Thursday. The company has a market cap of $102,300.00, a price-to-earnings ratio of 0.01 and a beta of 1.43. The stock has a fifty day moving average price of $0.08 and a two-hundred day moving average price of $0.56. TRACON Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $14.75.
TRACON Pharmaceuticals Company Profile
See Also
- Five stocks we like better than TRACON Pharmaceuticals
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Roth IRA Calculator: Calculate Your Potential Returns
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How to Invest in the Best Canadian Stocks
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for TRACON Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TRACON Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.